0
Clinical Investigations: COPD |

Ambulatory Oximetry Monitoring in Patients With Severe COPD*: A Preliminary Study

Jeffrey Pilling, MD; Michael Cutaia, MD, FCCP
Author and Funding Information

*From the Veterans Affairs Medical Center (Dr. Pilling), Pulmonary Disease Division, Department of Medicine, Brown University School of Medicine, Providence, RI; and the Veterans Affairs Medical Center (Dr. Cutaia), Research Service, Pulmonary Disease Division, University of Pennsylvania, Philadelphia, PA.

Correspondence to: Michael Cutaia, MD, FCCP, Veterans Affairs Medical Center, Research Service, Pulmonary Disease Division, University of Pennsylvania, Philadelphia, PA 19104; e-mail: mcutaia@mail.med.upenn.edu



Chest. 1999;116(2):314-321. doi:10.1378/chest.116.2.314
Text Size: A A A
Published online

Background: The benefits of long-term oxygen supplementation in COPD patients with hypoxemia are well established. The standard approach to prescribing oxygen uses a static assessment of oxygen requirements in a hospital or clinic setting. The assumption behind this approach is that patients will maintain a“ therapeutic” hemoglobin oxygen saturation (Spo2) in the outpatient setting. We questioned the validity of this assumption, and hypothesized that many patients may demonstrate significant oxygen desaturation during normal activities of daily living.

Study design, methods, and measurements: We determined if oxygen supplementation maintained a therapeutic Spo2 level in patients with COPD (n = 27), using the technique of ambulatory oximetry monitoring (AOM). AOM consisted of using a portable oximeter to monitor Spo2, pulse rate, and patient activity while patients were engaged in normal activities of daily living over an extended time period (∼18 h). The portable oximeter collected and stored these data every 15 s over the monitored time period. Each AOM recording was manually scored for desaturation events and other key variables, including average Spo2 over the monitoring period, the average number of desaturation events per hour, and the percentage of monitored time deleted secondary to artifacts.

Setting: University-affiliated Veterans Affairs Medical Center.

Patients: All subjects were patients with stable COPD with no recent history of hospitalization or exacerbation of their lung disease.

Results:This cohort of patients demonstrated a surprising frequency of desaturation below the recommended target Spo2 value (90%), which averaged approximately 25% of AOM recording time. There was wide variability among patients in the percentage of time Spo2 was below the target value (range, 3 to 67% of AOM recording time). Motion artifact on the AOM recordings was not a major problem; an average of 8% of the recording time was deleted secondary to artifacts in this patient cohort.

Conclusions: The results demonstrate that AOM is feasible and accurate with an acceptable level of motion artifact. These results also suggest that the standard approach for prescribing oxygen may lead to subtherapeutic Spo2 values in the outpatient setting. AOM holds promise as a tool to monitor the adequacy of oxygen prescriptions in the outpatient setting in patients with lung disease.

Figures in this Article

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543